17 Currently available GLP-1 RAs can be divided generally into 2 main categories on the basis of their pharmacokinetics: short- and long-acting agents
Blue Cross Blue Shield evaluates eligibility for weight loss surgery based on a combination of factors, including the severity of obesity, the presence of obesity-related comorbidities, and the failure of traditional weight loss methods
GLP-1 drugs are a class of medications that mimic the action of glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the intestines
For measuring out doses for your research, you'll want 1ml insulin syringes, marked in IU (International Units) or mL, for precision
54 In another phase 2 trial done to evaluate the efficacy of orforglipron in adults with obesity without diabetes, it was found to lead to significant weight reduction compared to placebo